Kuros Biosciences Ltd logo

Kuros Biosciences Ltd

XSWX:KURN (Switzerland)  
CHF 7.50 (-0.53%) Apr 19
At Loss
P/B:
4.86
Market Cap:
CHF 276.59M ($ 303.78M)
Enterprise V:
CHF 264.87M ($ 290.90M)
Volume:
112.63K
Avg Vol (2M):
208.41K
Also Trade In:
Volume:
112.63K
At Loss
Avg Vol (2M):
208.41K

Business Description

Description
Kuros Biosciences Ltd is a Swiss-based biopharmaceutical company focused on the development of innovative products for tissue repair and bone regeneration. It operates through the following segments: Medical devices, Pharmaceuticals and Legacy portfolio. The Medical devices segment includes products such as MagnetOs and Attrax. The Pharmaceuticals segment includes products such as Fibrin-PTH, a drug-biologic combination that promotes targeted and controlled bone formation through the induction of osteoprogenitor cell differentiation, enhancement, of osteoblast proliferation and increasing the lifespan of bone-forming cells. The Legacy portfolio segment includes all other products that do not belong to the group's core business strategy.
Name Current Vs Industry Vs History
Cash-To-Debt 6.47
Equity-to-Asset 0.79
Debt-to-Equity 0.04
Debt-to-EBITDA -0.21
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.51
Distress
Grey
Safe
Beneish M-Score -2.04
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 62.26
9-Day RSI 68.17
14-Day RSI 68.65
6-1 Month Momentum % 82.69
12-1 Month Momentum % 276.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.06
Quick Ratio 1.69
Cash Ratio 1.05
Days Inventory 156.89
Days Sales Outstanding 48.54
Days Payable 47.88

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.9
Shareholder Yield % -0.21

Financials

XSWX:KURN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Kuros Biosciences Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 33.564
EPS (TTM) (CHF) -0.38
Beta 1.03
Volatility % 93.16
14-Day RSI 68.65
14-Day ATR (CHF) 0.473676
20-Day SMA (CHF) 6.5405
12-1 Month Momentum % 276.98
52-Week Range (CHF) 1.11 - 8.17
Shares Outstanding (Mil) 36.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kuros Biosciences Ltd Filings

Filing Date Document Date Form
No Filing Data

Kuros Biosciences Ltd Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

Kuros Biosciences Ltd Frequently Asked Questions

What is Kuros Biosciences Ltd(XSWX:KURN)'s stock price today?
The current price of XSWX:KURN is CHF7.50. The 52 week high of XSWX:KURN is CHF8.17 and 52 week low is CHF1.11.
When is next earnings date of Kuros Biosciences Ltd(XSWX:KURN)?
The next earnings date of Kuros Biosciences Ltd(XSWX:KURN) is .
Does Kuros Biosciences Ltd(XSWX:KURN) pay dividends? If so, how much?
Kuros Biosciences Ltd(XSWX:KURN) does not pay dividend.

Press Release

Subject Date
No Press Release